Certified by Founder Lodge
Complement Therapeutics
United Kingdom - London
START UP
1 Disclosed Funding Rounds $78,929,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Complement Therapeutics (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout
Date | Round | Raised | Participating Investors |
---|---|---|---|
April, 18 ,2023 | Series A | $78,929,000 | |
April, 19 ,2023 | Series A | Undisclosed Amount |